This inventor holds 7 USPTO granted patents and 5 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Amtixbio Co., Ltd., Cureverse Incorporated, Megabiowood Co., Ltd. Active years: 2020-2025.
Company Filing History:
4 out of 4 
1 out of 1 
1 out of 1 Years Active: 2020-2025
Title: Seul Ki Yeon: Innovator in Pharmaceutical Chemistry
Introduction
Seul Ki Yeon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of seven patents. His work focuses on developing novel compounds with potential therapeutic applications.
Latest Patents
Among his latest patents is the invention of a halo-(3-(phenylsulfonyl)prop-1-enyl)pyridine derivative. This innovative compound is designed to act as an Nrf2 activator, which is crucial for preventing or treating diseases associated with decreased Nrf2 activity. Another notable patent involves a method for preparing an aminoalkanoic acid derivative containing a biphenyl group. This compound demonstrates excellent antifungal and fungicidal effects, showcasing broad-spectrum activity against various fungal pathogens.
Career Highlights
Seul Ki Yeon has worked with several companies, including Amtixbio Co., Ltd. and Cureverse Incorporated. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and innovation.
Collaborations
Throughout his career, Seul Ki Yeon has collaborated with notable colleagues, including Ki Duk Park and Ji Won Choi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Seul Ki Yeon is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in antifungal treatments and Nrf2 activators. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.